Log In
BCIQ
Print this Print this
 

BTA074 (formerly AP611074)

  Manage Alerts
Collapse Summary General Information
Company Aviragen Therapeutics Inc.
DescriptionInhibitor of E1 and E2 viral proteins of HPV types 6 and 11
Molecular Target E1 protein (Human papillomavirus-16) (HpV16gp3) ; E2 regulatory protein (Human papillomavirus-16) (HpV16gp4)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationGenital warts
Indication DetailsTreat genital warts (condylomas)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today